Chemistry: analytical and immunological testing – Clotting or clotting factor level tests
Patent
1998-07-31
1999-11-09
Warden, Jill
Chemistry: analytical and immunological testing
Clotting or clotting factor level tests
422 73, 435 2, 435 13, 4352887, 364496, 364497, 364498, 364499, 73 6441, 7341307, 7341308, 7341309, G01N 3386
Patent
active
059812850
ABSTRACT:
A method and apparatuses are disclosed for determining an anticoagulant therapy factor (ATF), a corrected anticoagulant therapy factor (CATF), and a modified anticoagulant therapy factor (MATF), all selectively used for monitoring oral anticoagulant therapy to help prevent excessive bleeding or deleterious blood clots that might otherwise occur before, during or after surgery. The anticoagulant therapy factor (ATF), the corrected anticoagulant therapy factor (CATF), and a modified anticoagulant therapy factor (MATF) are based upon disclosed methods for determining the fibrinogen transformation rate (FTR) which, in turn, is dependent on a maximum acceleration point for fibrinogen (FBG) conversion. The ATF, CATF, and MATF quantities are also based upon the prothrombin time (PT), but have no need for the difficulty to obtain prior art International Normalized Ratio (INR) and International Sensitivity Index (ISI) parameters. The International Normalized Ratio (INR) was created to relate all species' clotting material to human clotting material. The AFT, CATF, and MATF quantities embody only human clotting material. The ATF, CATF, and MATF quantities and International Normalized Ratio (INR) are, hereby, species specific and provide the same results.
REFERENCES:
patent: 3458287 (1969-07-01), Gross et al.
patent: 3593568 (1971-07-01), Schmitz
patent: 3905769 (1975-09-01), Carroll et al.
patent: 4217107 (1980-08-01), Saito et al.
patent: 4279616 (1981-07-01), Saito et al.
patent: 4720787 (1988-01-01), Lipscomb
patent: 4788139 (1988-11-01), Ryan
patent: 5156974 (1992-10-01), Grossman et al.
patent: 5188940 (1993-02-01), Krause et al.
patent: 5197017 (1993-03-01), Carroll et al.
patent: 5502651 (1996-03-01), Carroll et al.
patent: 5526111 (1996-06-01), Collins et al.
Hirsh et al., "Special Report: A Simple System for the Derivation of International Normalized Ratios for the Reporting of Prothrombin Time Results with North American Thromboplastin Reagents;" Am. J. Clin. Pathol, 92, pp. 124-126, 1989.
Ebert Ray "PTs, PRs, ISIs, and INRs: A Primer on Prothrombin Time Reporting: Part I: Calibration of Thromboplastin Reagents and Principles of Prothrombin Time Reporting", Clinical Hemostasis Review vol. 7, No. 11, Nov. 1993.
Ebert, Ray PTs, PRs, ISIs, and INRs: A Primer on Prothrombin Time Reporting: Part II: Limitations of INR Reporting: Clinical Hemostasis Review, vol. 7, No. 12, Dec. 1993.
Solymoss et al. Markers of In Vivo Activation of Coagulation Interrelationships change with Intensity of Oral Anticoagulation A.J.C.P, vol. 105 No. 3, pp. 293-297, Mar. 1996.
Medical Group Pathology Laboratory Protime INR Values, Jul. 1, 1990.
Fibrinogen Determinations: An Automated Photoelectric System, A.B. Glassman, J.H. Maylock, J.H. Hudson (1972).
Rapid Determination of Fibrinogen by Thrombokinetics, A.J.C.P. --vol. 61, Ethan A. Natelson and Denise F. Dooley (Jun. 1974) pp. 828-833.
Research Communications in Molecular Pathology & Pharmacology, Rapid Fibrinogen Determination with the Prothrombin Time Using a Potentiophotometer, vol. 86, No. 1, Jul. 1995.
"Baxter Diagnostics, Inc. --Dade Determination of INR (International Normalized Ratio", Aug. 1994.
Baxter Diagnostics, Inc.--Dade Determination of INR (International Normalized Ratio), Jan. 1992.
Carroll Wallace E.
Jackson R. David
A. Earley John F.
A. Earley III John F.
Carrillo S.
Warden Jill
LandOfFree
Method and apparatus for determining anticoagulant therapy facto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for determining anticoagulant therapy facto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for determining anticoagulant therapy facto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1454667